Destiny Pharma (LSE:DEST) Total Assets : £9.96 Mil (As of Dec. 2023)

View and export this data going back to 2017. Start your Free Trial

What is Destiny Pharma Total Assets?

Destiny Pharma's Total Assets for the quarter that ended in Dec. 2023 was £9.96 Mil.

During the past 12 months, Destiny Pharma's average Total Assets Growth Rate was -8.20% per year. During the past 3 years, the average Total Assets Growth Rate was -3.40% per year. During the past 5 years, the average Total Assets Growth Rate was 33.70% per year.

During the past 10 years, Destiny Pharma's highest 3-Year average Total Assets Growth Rate was 122.60%. The lowest was -5.50%. And the median was 53.90%.

Total Assets is connected with ROA %. Destiny Pharma's annualized ROA % for the quarter that ended in Dec. 2023 was -52.11%. Total Assets is also linked to Revenue through Asset Turnover. Destiny Pharma's Asset Turnover for the quarter that ended in Dec. 2023 was 0.00.

Destiny Pharma Total Assets Historical Data

The historical data trend for Destiny Pharma's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Destiny Pharma Total Assets Chart

Destiny Pharma Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Assets

Get a 7-Day Free Trial

8.56

13.71

8.28

8.80

9.96

Destiny Pharma Semi-Annual Data
	Dec14	Dec15	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Total Assets	Get a 7-Day Free Trial												8.28	11.50	8.80	13.05	9.96

Destiny Pharma Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Destiny Pharma's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets	=	Total Equity (A: Dec. 2023 )	+	Total Liabilities (A: Dec. 2023 )
	=	9.189	+	0.768
	=	9.96

Destiny Pharma's Total Assets for the quarter that ended in Dec. 2023 is calculated as

Total Assets	=	Total Equity (Q: Dec. 2023 )	+	Total Liabilities (Q: Dec. 2023 )
	=	9.189	+	0.768
	=	9.96

Destiny Pharma (LSE:DEST) Total Assets Explanation

Total Assets is connected with ROA %.

Destiny Pharma's annualized ROA % for the quarter that ended in Dec. 2023 is

ROA %	=	Net Income (Q: Dec. 2023 )	/	( (Total Assets (Q: Jun. 2023 )	+	Total Assets (Q: Dec. 2023 ))	/ count )
	=	-5.994	/	( (13.046	+	9.957)	/ 2 )
	=	-5.994	/	11.5015
	=	-52.11 %

Note: The Net Income data used here is two times the semi-annual (Dec. 2023) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Destiny Pharma's Asset Turnover for the quarter that ended in Dec. 2023 is

	Asset Turnover
=	Revenue (Q: Dec. 2023 )	/	( (Total Assets (Q: Jun. 2023 )	+	Total Assets (Q: Dec. 2023 ))	/ count )
=	0	/	( (13.046	+	9.957)	/ 2 )
=	0	/	11.5015
=	0.00

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Destiny Pharma Total Assets Related Terms

Thank you for viewing the detailed overview of Destiny Pharma's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Destiny Pharma (LSE:DEST) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Destiny Pharma PLC (LSE:DEST) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

D89:Germany

Address

Unit 36, Sussex Innovation Centre, Science Park Square, Falmer, Brighton, GBR, BN1 9SB

Website

https://www.destinypharma.com

Destiny Pharma PLC is a clinical-stage biotechnology company which is focused on the development of medicines for the treatment of infectious disease. It is developing drugs for the prevention and treatment of infections caused by Antibiotic-Resistant (AR) bacteria. It is involved in developing XF-73 Dermal for the treatment of skin infections of antibiotic-resistant bacteria, XF-73 Nasal for prevention of post-surgical staphylococcal infection, XF Throat for prevention of staphylococcal hospital/ventilator-associated pneumonia infection.

Destiny Pharma (LSE:DEST) Headlines

No Headlines